UnitedHealth (UNH) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates

Core Insights - UnitedHealth Group reported revenue of $109.58 billion for the quarter ended March 2025, reflecting a year-over-year increase of 9.8% [1] - The earnings per share (EPS) for the quarter was $7.20, up from $6.91 in the same quarter last year, but below the consensus estimate of $7.27, resulting in an EPS surprise of -0.96% [1] Financial Performance - The reported revenue was 1.40% below the Zacks Consensus Estimate of $111.13 billion [1] - The Medical Care Ratio was reported at 84.8%, better than the estimated 85.9% [4] - Total revenues from UnitedHealthcare reached $84.62 billion, exceeding the average estimate of $83.20 billion, with a year-over-year change of +12.3% [4] Customer Metrics - The number of risk-based customers served by UnitedHealthcare was 8.41 million, lower than the average estimate of 9 million [4] - Fee-based customers served totaled 21.59 million, slightly above the average estimate of 21.46 million [4] - Total community and senior customers served was 20.13 million, close to the average estimate of 20.16 million [4] Revenue Breakdown - Investment and other income was reported at $1.03 billion, slightly below the average estimate of $1.06 billion, with a year-over-year change of +2.2% [4] - Product revenues were $13.04 billion, compared to the average estimate of $13.33 billion, reflecting a year-over-year increase of +9.5% [4] - Service revenues were $8.97 billion, below the average estimate of $9.76 billion, with a year-over-year change of +1% [4] - Premium revenues reached $86.53 billion, slightly below the average estimate of $86.94 billion, with a year-over-year increase of +11% [4] - Optum Insight revenues were $4.63 billion, below the average estimate of $5.11 billion, with a year-over-year change of +2.8% [4] - Optum Rx revenues were $35.13 billion, exceeding the average estimate of $34.11 billion, with a year-over-year increase of +13.9% [4] - Optum Health revenues were reported at $25.31 billion, significantly below the average estimate of $28.97 billion, reflecting a year-over-year decrease of -5.3% [4] Stock Performance - UnitedHealth shares have returned +16.3% over the past month, outperforming the Zacks S&P 500 composite, which declined by -6.3% [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential for outperformance in the near term [3]